monitoring response to primary hormonal treatment (PMH) in older ladies with oestrogen responsive (ER +ve ) breast cancer. Are we giving the best to these patients?
Association of Breast Surgery ePoster Library. Bright-Thomas R. 05/15/17; 166179; P145
Rachel Bright-Thomas
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
Introduction
The proportion of the population over age 80 is increasing nationally. By 2050 it will be 1 in 10, 2/3 being women. Breast cancer is common in this group (1 in 14) and is predominantly ER +ve (90%). Many affected women have other co-morbidities and prefer to avoid surgical treatment if possible. One common treatment option is to commence primary hormonal manipulation (PHM) and to monitor response sequentially until this treatment fails. This has resource implications as the patients require frequent follow up and, with a good response, may need to return for focused USS assessment. Hearing and mobility issues can also prolong the appointment time required.
Methods
Since 2014 we have collated a prospective record of >50 patients over age 80 treated with PHM. After receiving initial written information about treatment options, those choosing PMH are followed up in a dedicated nurse led clinic with, telephone reminders of clinic appointments, simultaneous USS available, more clinic time for assessment of cancer response and holistic assessment of needs, and open access back into the main clinic if the drug response is poor or if the patient wishes to try an alternative treatment path.
Results
Patients, carers and our support group have rated the information leaflet highly, and have found the clinic “easy” and “smooth” to attend.
Conclusions
We commend this approach to other units, both to streamline other busy follow up clinics and for improved patient satisfaction so that all patients may receive the first-class treatment that they deserve.
The proportion of the population over age 80 is increasing nationally. By 2050 it will be 1 in 10, 2/3 being women. Breast cancer is common in this group (1 in 14) and is predominantly ER +ve (90%). Many affected women have other co-morbidities and prefer to avoid surgical treatment if possible. One common treatment option is to commence primary hormonal manipulation (PHM) and to monitor response sequentially until this treatment fails. This has resource implications as the patients require frequent follow up and, with a good response, may need to return for focused USS assessment. Hearing and mobility issues can also prolong the appointment time required.
Methods
Since 2014 we have collated a prospective record of >50 patients over age 80 treated with PHM. After receiving initial written information about treatment options, those choosing PMH are followed up in a dedicated nurse led clinic with, telephone reminders of clinic appointments, simultaneous USS available, more clinic time for assessment of cancer response and holistic assessment of needs, and open access back into the main clinic if the drug response is poor or if the patient wishes to try an alternative treatment path.
Results
Patients, carers and our support group have rated the information leaflet highly, and have found the clinic “easy” and “smooth” to attend.
Conclusions
We commend this approach to other units, both to streamline other busy follow up clinics and for improved patient satisfaction so that all patients may receive the first-class treatment that they deserve.
Introduction
The proportion of the population over age 80 is increasing nationally. By 2050 it will be 1 in 10, 2/3 being women. Breast cancer is common in this group (1 in 14) and is predominantly ER +ve (90%). Many affected women have other co-morbidities and prefer to avoid surgical treatment if possible. One common treatment option is to commence primary hormonal manipulation (PHM) and to monitor response sequentially until this treatment fails. This has resource implications as the patients require frequent follow up and, with a good response, may need to return for focused USS assessment. Hearing and mobility issues can also prolong the appointment time required.
Methods
Since 2014 we have collated a prospective record of >50 patients over age 80 treated with PHM. After receiving initial written information about treatment options, those choosing PMH are followed up in a dedicated nurse led clinic with, telephone reminders of clinic appointments, simultaneous USS available, more clinic time for assessment of cancer response and holistic assessment of needs, and open access back into the main clinic if the drug response is poor or if the patient wishes to try an alternative treatment path.
Results
Patients, carers and our support group have rated the information leaflet highly, and have found the clinic “easy” and “smooth” to attend.
Conclusions
We commend this approach to other units, both to streamline other busy follow up clinics and for improved patient satisfaction so that all patients may receive the first-class treatment that they deserve.
The proportion of the population over age 80 is increasing nationally. By 2050 it will be 1 in 10, 2/3 being women. Breast cancer is common in this group (1 in 14) and is predominantly ER +ve (90%). Many affected women have other co-morbidities and prefer to avoid surgical treatment if possible. One common treatment option is to commence primary hormonal manipulation (PHM) and to monitor response sequentially until this treatment fails. This has resource implications as the patients require frequent follow up and, with a good response, may need to return for focused USS assessment. Hearing and mobility issues can also prolong the appointment time required.
Methods
Since 2014 we have collated a prospective record of >50 patients over age 80 treated with PHM. After receiving initial written information about treatment options, those choosing PMH are followed up in a dedicated nurse led clinic with, telephone reminders of clinic appointments, simultaneous USS available, more clinic time for assessment of cancer response and holistic assessment of needs, and open access back into the main clinic if the drug response is poor or if the patient wishes to try an alternative treatment path.
Results
Patients, carers and our support group have rated the information leaflet highly, and have found the clinic “easy” and “smooth” to attend.
Conclusions
We commend this approach to other units, both to streamline other busy follow up clinics and for improved patient satisfaction so that all patients may receive the first-class treatment that they deserve.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}